Home
 /
Papers
 /
Neuroscience
 /
Synaptic proteins that aggregate and degrade slower with aging accumulate in microglia
Preprint
Open access
V1
Top 1% · Validated by QED

Synaptic proteins that aggregate and degrade slower with aging accumulate in microglia

Ian H. Guldner, Viktoria P. Wagner, Patricia Moran-Losada +16 more
May 2025
 ·
bioRxiv
 ·
DOI 
10.1101/2025.05.20.654652
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Neuroscience this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

New in vivo labeling tools reveal that neuronal protein degradation halves with aging, synaptic proteins dominate the aged aggregome, and microglia selectively clear proteostatically stressed synapses—establishing synaptic proteostasis failure as a root cause of neurodegeneration.

QED claims analysis

Summary

Using novel bioorthogonal protein labeling tools, this study reveals that neuronal protein degradation slows approximately two-fold with aging in mice, leading to accumulation of 574 aggregating proteins enriched for synaptic components, 65% of which are selectively transferred to microglia, suggesting a cascade from impaired synaptic protein turnover through aggregation to microglial disposal that may underlie age-related synapse loss and cognitive decline.

See full analysis
Main Claim 1 –

PheRS* BONCAT Enables Superior Cell-Specific Nascent Proteome Labeling

Supporting evidence

  • PheRS* BONCAT Reveals Region-Specific Camk2a+ Neuronal Proteome Signatures
Main Claim 2 –

Neuronal Protein Degradation Doubles Slower with Aging, Varies by Region

Supporting evidence

  • AAV-PheRS* Enables Robust Neuronal Proteome Labeling in Aged Mice
  • Pathway-Linked Proteins Exhibit Coordinated Degradation and Age-Specific Vulnerability
Main Claim 3 –

Aged Neuronal Aggregome Contains 574 Synapse-Enriched, Slow-Degrading Proteins

Main Claim 4 –

Microglia Accumulate 274 Neuronal Proteins with Age-Related Proteostasis Deficits

Abstract

Neurodegenerative diseases affect 1 in 12 people globally and remain incurable. Central to their pathogenesis is a loss of neuronal protein maintenance and the accumulation of protein aggregates with aging. We engineered bioorthogonal tools which allowed us to tag the nascent neuronal proteome and study its turnover with aging, its propensity to aggregate, and its interaction with microglia. We discovered neuronal proteins degraded on average twice as slowly between 4- and 24-month-old mice with individual protein stability differing between brain regions. Further, we describe the aged neuronal ‘aggregome’ encompassing 574 proteins, nearly 30% of which showed reduced degradation. The aggregome includes well-known proteins linked to disease as well as a trove of proteins previously not associated with neurodegeneration. Unexpectedly, we found 274 neuronal proteins accumulated in microglia with 65% also displaying reduced degradation and/or aggregation with age. Among these proteins, synaptic proteins were highly enriched, suggesting a cascade of events emanating from impaired synaptic protein turnover and aggregation to the disposal of these proteins, possibly by the engulfment of synapses by microglia. These findings reveal the dramatic loss of neuronal proteome maintenance with aging which could be causal for age-related synapse loss and cognitive decline.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?